Grace TherapeuticsGRCE
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 17 institutions reported holding Grace Therapeutics Inc. (GRCE) in their 13F filings, up 2 from Q4 2024. 3 opened new positions and 1 sold out. The largest holders were AIGH Capital Management LLC ($3.0M), Nantahala Capital Management, LLC ($2.7M) and Bank of America Corp. ($1.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Grace Therapeutics Inc.
- CUSIP
- 00439U104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $3.5M |
| Exits | 1 | $116 |
All 13F filers, Q4 2024 → Q1 2025: 2,367,227 shares bought and 431,015 shares sold, net +1,936,212 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| AIGH Capital Management LLC | 1.56% | Add +153.8% | 1,322,379 | $3.0M |
| Nantahala Capital Management, LLC | 0.22% | New | 1,178,203 | $2.7M |
| Bank of America Corp. | 0.00% | No change | 494,698 | $1.1M |
| ADAR1 Capital Management, LLC | 0.16% | Reduce -55.6% | 343,512 | $783K |
| Stonepine Capital Management, LLC | 0.65% | New | 294,550 | $666K |
| Vanguard Group Inc. | 0.00% | Add +13.5% | 255,400 | $582K |
| Palumbo Wealth Management LLC | 0.04% | New | 46,007 | $105K |
| Renaissance Technologies | 0.00% | Reduce -1.9% | 42,181 | $96K |
| Citadel Advisors | 0.00% | Add +62.3% | 38,403 | $88K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +129.1% | 3,429 | $8K |
| National Bank of Canada | 0.00% | Reduce -0.0% | 2,718 | $6K |
| Morgan Stanley | 0.00% | Reduce -1.8% | 1,848 | $4K |
| Royal Bank of Canada | 0.00% | Reduce -0.6% | 543 | $1K |
| Activest Wealth Management | 0.00% | No change | 104 | $237 |
| SBI Securities Co., Ltd. | 0.00% | Add +10000.0% | 101 | $230 |
| JPMorgan Chase & Co. | 0.00% | Reduce -11.8% | 15 | $34 |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -96.4% | 1 | $2 |
"% of holder's portfolio" is GRCE's weight in each manager's 13F, not the share of Grace Therapeutics Inc. the manager owns.